---

Anti-diabetic nephropathy compounds from Cinnamomum cassia

Authors Yan, Yong-Ming; Fang, Ping; Yang, Mu-Tian; Li, Ning; Lu, Qing; Cheng, Yong-Xian

Journal JOURNAL OF ETHNOPHARMACOLOGY , MAY 13 2015,:165

DOI 10.1016/j.jep.2015.01.049 PubMed 25725434

Abstract Ethnopharmacological relevance: The bark of Cinnamomum cassia, called ''Rou-Gui'', a traditional spice and medicine in China, is used to treat diseases resulted from kidney yang deficiency, including diabetic nephropathy. The aim of this study is to investigate the anti-diabetic nephropathy activity of Rou-Gui and the active compounds in it.Materials and methods: The air-dried bark of C cassia was extracted with 90% EtOH, the obtained residue was successively partitioned by petroleum ether, EtOAc, and n-BuOH followed by concentrating to give petroleum ether (RG-1), EtOAc (RG-2), n-BuOH (RG-3), and water fraction (RG-4), respectively. The antidiabetic nephropathy activity of fraction (RG-1-4) was evaluated in vitro by inhibiting the expression of fibronectin, monocyte chemoattractant protein-1 and interleukin-6 in high-glucose-induced mesangial cells. By bioassay screenings, repeated column chromatography on fractions of RG-1, 2, and 3, led to the isolation of 23 compounds, whose structures were determined by extensive spectroscopic analyses, and the anti-diabetic nephropathy activity of the isolated compounds was also evaluated.Results: Four new sesquiterpenoids, cinnamoids A-D (1-4), a new natural product (5), and 18 known compounds (6-23) were isolated from the EtOH extract of the bark of C cassia under the bioassay-guided screenings. The anti-diabetic nephropathy activity assay showed that fractions of RG-1, 2, and 3 could significantly inhibit the production of fibronectin, monocyte chemoattractant protein-1 and interleukin-6 in high-glucose-stimulated mesangial cells at the concentration of 50 mu g/ml; and sesquiterpenoids 5, 6, 14 and compound 20 could significantly inhibit the expression of fibronectin, monocyte chemoattractant protein-1 and interleukin-6 at the concentration of 50 mu M.Conclusions: The results revealed that sesquiterpenoids may be the active compounds in C cassia bark on diabetic nephropathy which provided new evidences for the traditional use of this herb to treat diabetic nephropathy and associated kidney diseases. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

Species covered 肉桂 Cinnamomum cassia